Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$1.02B |
| 2 |
Canadian Natural Resources
CNQ
|
+$958M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$896M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$861M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$756M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.62B |
| 2 |
Amgen
AMGN
|
+$1.68B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.18B |
| 4 |
Visa
V
|
+$1.05B |
| 5 |
Invesco QQQ Trust
QQQ
|
+$1B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.79% |
| 2 | Healthcare | 9.32% |
| 3 | Financials | 8.97% |
| 4 | Consumer Discretionary | 7.33% |
| 5 | Industrials | 5.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
WD-40
WDFC
$3.1B
| $11.9M | ﹤0.01% |
73,802
-5,639
| -7% | -$941K |
|
2402
Merit Medical Systems
MMSI
$5.24B
| $11.9M | ﹤0.01% |
168,448
+25,105
| +18% | +$1.68M |
|
2403
Duolingo
DUOL
$5.74B
| $11.9M | ﹤0.01% |
167,038
+79,599
| +91% | +$6.21M |
|
2404
CALL
CrowdStrike
CRWD
$211B
| $11.9M | ﹤0.01% |
450,800
-51,200
| -10% | -$1.75M |
|
2405
Deluxe
DLX
$1.19B
| $11.8M | ﹤0.01% |
696,909
-318,994
| -31% | -$5.68M |
|
2406
A10 Networks
ATEN
$1.99B
| $11.8M | ﹤0.01% |
711,425
+188,186
| +36% | +$3.22M |
|
|
MRSN
2407
DELISTED
Mersana Therapeutics
MRSN
| $11.8M | ﹤0.01% |
80,580
-15,579
| -16% | -$2.63M |
|
2408
Cracker Barrel
CBRL
$1.3B
| $11.8M | ﹤0.01% |
124,428
+65,966
| +113% | +$6.87M |
|
2409
PUT
DoorDash
DASH
$92.4B
| $11.7M | ﹤0.01% |
240,500
+73,000
| +44% | +$3.79M |
|
|
MRC
2410
DELISTED
MRC Global
MRC
| $11.7M | ﹤0.01% |
1,011,745
-48,407
| -5% | -$511K |
|
2411
Krystal Biotech
KRYS
$9.55B
| $11.7M | ﹤0.01% |
147,601
+5,216
| +4% | +$387K |
|
2412
International Seaways
INSW
$4.61B
| $11.7M | ﹤0.01% |
315,540
+101,796
| +48% | +$4.12M |
|
2413
Q2 Holdings
QTWO
$3.95B
| $11.6M | ﹤0.01% |
432,889
+170,985
| +65% | +$4.78M |
|
2414
Steven Madden
SHOO
$3.53B
| $11.6M | ﹤0.01% |
363,796
+19,601
| +6% | +$613K |
|
2415
ESAB
ESAB
$5.88B
| $11.6M | ﹤0.01% |
247,464
-161,415
| -39% | -$6.75M |
|
2416
e.l.f. Beauty
ELF
$5.44B
| $11.6M | ﹤0.01% |
209,799
-233,898
| -53% | -$11.5M |
|
2417
iShares iBonds Dec 2027 Term Treasury ETF
IBTH
$2.27B
| $11.6M | ﹤0.01% |
+520,000
| New | +$11.6M |
|
|
BRSP
2418
BrightSpire Capital
BRSP
$639M
| $11.6M | ﹤0.01% |
1,855,540
+91,164
| +5% | +$633K |
|
2419
Brinker International
EAT
$9.75B
| $11.6M | ﹤0.01% |
362,250
+60,484
| +20% | +$1.9M |
|
|
GTY
2420
Getty Realty Corp
GTY
$2.06B
| $11.5M | ﹤0.01% |
341,004
-108,024
| -24% | -$3.41M |
|
2421
Bilibili
BILI
$7.81B
| $11.5M | ﹤0.01% |
486,391
-48,454
| -9% | -$771K |
|
2422
CALL
Biogen
BIIB
$30.5B
| $11.5M | ﹤0.01% |
41,600
-10,000
| -19% | -$2.82M |
|
2423
Twist Bioscience
TWST
$6.84B
| $11.5M | ﹤0.01% |
482,401
-204,897
| -30% | -$5.94M |
|
2424
Innovative Industrial Properties
IIPR
$1.69B
| $11.5M | ﹤0.01% |
113,221
+24,834
| +28% | +$2.64M |
|
2425
Valmont Industries
VMI
$9.5B
| $11.5M | ﹤0.01% |
34,665
-8,174
| -19% | -$2.59M |
|
Similar funds
Goldman Sachs's Q4 2022 Portfolio in Review
As of Q4 2022, Goldman Sachs held 6,669 positions worth $408B, up 3.1% from $396B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $13.2B in Q4 2022, closing 721 positions and reducing 2,588 holdings. Its most notable exit was ChemoCentryx, Inc., an estimated $290M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Goldman Sachs opened a new position in Perfect Corp worth $104M.
- Goldman Sachs's largest Q4 2022 buy was Perfect Corp: 14,518,235 shares worth $104M.
- Goldman Sachs added most to Vanguard Total Bond Market in Q4 2022, an estimated $1.02B increase.
- Goldman Sachs's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.62B.
- Goldman Sachs fully exited ChemoCentryx, Inc. in Q4 2022, selling an estimated $290M.
- Goldman Sachs's ten largest holdings make up 15% of its $408B portfolio in Q4 2022.
- Goldman Sachs opened 429 new positions and closed 721 in Q4 2022.
- Goldman Sachs's portfolio value rose 3.1% quarter-over-quarter to $408B.
Based on Goldman Sachs's 13F filing for Q4 2022, filed 13 Feb 2023.